The regulatory environment in the UK and Europe is seeing significant structural change. In the UK, the FCA is reviewing the investment and corporate broking model, while the EU’s draft rules under MiFID II could see corporate access as an inducement and much tighter controls around the payment for research. With this rapidly changing landscape, IR technology platforms are on the rise, taking advantage of these proposed regulatory changes. They are looking to offer in-house the opportunity to take more control over their engagement with the shareholder community, as well as provide add-on IR services. Can technology offer a complete IR solution? Will regulatory change positively impact IR in terms of budgets, resources and IR team sizes? Will these changes help fill any perceived gaps on the buy- and sell-side?